LBO France
LBO France is a private equity firm that supports French and Italian companies in their growth.
Business Model:
Revenue: $31.5M
Employees: 51-200
Rankings
Industries / Tags:
Detailed LBO France Information
Geographic Data
Address: 148 rue de l'Universite
City: Paris
State: île-de-france
Zip: 75007
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$181M
Social
Linkedin
Crunchbase
Metrics
3,357,764Website Global Rank
4,715Website Monthly Traffic
Twitter Followers
Description
LBO France is private equity firms in France. They offer exceptional coverage of the French market, with four interlocking areas of expertise: middle market buyouts (the White Knight funds), small cap buyouts (the Hexagone funds), real estate (the White Stone and Lapillus funds) and secondary debt (the Altercap funds). This breadth of specialist knowledge makes us a private equity leader in France – the second-largest economy in Europe and the fifth-largest in the world. With seasoned and diversified teams, a well-established position and in-depth knowledge of the French economy, LBO France offers management and investors of portfolio companies a wealth of experience and opportunities that spur value creation.. Their strategy of diversification and growth has enabled us to achieve a critical mass that allows us to devote substantial financial and human resources to continuously improve the services they provide to their portfolio companies and investors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2019 | Ecritel Group | Private Equity Round | - |
| 4/2021 | Meditect | Seed Round | 1.8M |
| 3/2022 | FeetMe | Convertible Note | - |
| 9/2022 | SiVIEW | Series A | 5.5M |
| 12/2020 | Kayentis | Venture Round | 0 |
| 11/2018 | Stilla Technologies | Series A | 18.3M |
| 2/2020 | Stilla Technologies | Series B | 0 |
| 6/2018 | BIOMODEX | Series A | 15M |
| 7/2022 | Impress | Series B | 0 |
| 6/2021 | Antidote.me | Venture Round | 0 |
| 9/2017 | BioSerenity | Series A | 17.8M |
| 6/2022 | Diabeloop | Series C | 0 |
| 1/2022 | Wandercraft | Series C | 0 |
| 2/2023 | hemea (ex-Travauxlib) | Venture Round | 10.8M |
| 9/2019 | Quantificare | Series A | 5.5M |
| 5/2021 | Hosman | Venture Round | 0 |
| 1/2012 | Labeyrie Fine Foods | Private Equity Round | - |
| 11/2010 | Flash | Private Equity Round | - |
| 9/2022 | TEAMOTY | Series A | 2.9M |
| 6/2019 | BioSerenity | Series B | 0 |
| 9/2019 | FeetMe | Series A | 10.4M |
| 11/2021 | Stilla Technologies | Debt Financing | 0 |
| 9/2022 | Incepto Medical | Venture Round | 0 |
| 3/2020 | Colonies | Series B | 0 |
| 7/2022 | Impress | Series B | 0 |
| 6/2022 | Diabeloop | Series C | 0 |
| 1/2022 | Wandercraft | Series C | 0 |
| 11/2021 | Stilla Technologies | Debt Financing | 0 |
| 6/2021 | Antidote.me | Venture Round | 0 |
| 5/2021 | Hosman | Venture Round | 0 |
| 4/2021 | Meditect | Seed Round | 0 |
| 12/2020 | Kayentis | Venture Round | 0 |
| 3/2020 | Colonies | Series B | 0 |
| 2/2020 | Stilla Technologies | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
